Clinical trial
A Prospective Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh(Seratom PA®) in Patients With Pelvic Organ Prolapsed
NCT02320643 is registered in ClinicalTrials.gov with Samyang Biopharmaceuticals Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh(Seratom PA®) in Patients With Pelvic Organ Prolapsed
- Lead sponsor
- Samyang Biopharmaceuticals Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- April 30, 2017
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.